Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 252,898	$ 220,645
Prepaid expenses and other current assets	32,630	40,632
Total current assets	285,528	261,277
Total assets	285,528	261,277
Current liabilities:
Accounts payable	116,421	133,464
Derivative liability	0	46,700
Accrued compensation	2,993,793	2,399,132
Accrued consulting	809,528	753,570
Accrued expenses and other	649,225	584,808
Total current liabilities	4,568,967	3,917,674
Convertible notes, net	1,297,590	1,228,361
Total liabilities	5,866,557	5,146,035
Commitments and contingencies
Stockholders’ deficit:
Common stock, $0.00001 par value: 100,000,000 shares authorized: 7,242,137 shares issued and outstanding	72	72
Additional paid-in capital	2,039,677	2,023,271
Accumulated deficit	(7,620,779)	(6,908,102)
Total stockholders’ deficit	(5,581,029)	(4,884,758)
Total liabilities and stockholders’ deficit	285,528	261,277
Series A Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock, value	0	0
Series B Preferred Stock [Member]
Stockholders’ deficit:
Preferred stock, value	$ 1	$ 1